ClinicalTrials.gg
CompletedNCT03839732CALCIFY2DUpdated May 24, 2023

Observer Variability in Scoring Abdominal Aortic Calcifications and Vertebral Morphometry

An observational study in Vascular Calcification and Vertebral Fracture, sponsored by Istituto Ortopedico Rizzoli. Completed at 1 site in Italy. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2023-05-24.

Sponsored by Istituto Ortopedico Rizzoli · Observational

Study type
Observational
Model
Case-only
Time perspective
Retrospective
Enrollment
44
Ages
20 Years and older
Sex
All
01

Study summary

BACKGROUND In the context of a progressively aging population, monitoring the status of Vascular Calcifications (VC) and Vertebral Fractures (VF) over time would be of primary importance, as VC and VF are recognized to be hallmarks of severe cardiovascular events (hospitalization and/or death) and hip fractures respectively, and VF represent an under-diagnosed cause of progressive disability and pain on its own. Moreover, there is an acknowledged relationships between VC and VF.

However, data about the emergence/progression of VC and the emergence/worsening of VF over time are lacking. This is likely due to the absence of monitoring instruments for VC and VF that are both precise and easily accessible/applicable.

OBJECTIVE This study aims to define the observer variability of a new software developed by the study sponsor and collaborators, called Calcify2D. Calcify2D offers physicians a computer-assisted procedure to simultaneously score vascular calcifications at the abdominal aorta and lumbar vertebral fractures (according to Quantitative Vertebral Morphometry principles) based on a latero-lateral thoracolumbar spine radiography. Secondary aims are the validation of the scores obtained from latero-lateral thoracolumbar spine radiography with more invasive and/or costly gold-standard imaging modalities (Computed Tomography for VC, Magnetic Resonance for VF) that may have been acquired near-simultaneously to radiographs on the patients enrolled for the study.

STUDY DESIGN Not-for-profit monocentric observational study to be conducted on the diagnostic images of the thoracolumbar spine already collected at Istituto Ortopedico Rizzoli (IOR) within a previous interventional study.

Scoring of VC and VF will be performed by four clinicians from four relevant specialties, chosen among those who may often see VC and VF and are already familiar with the traditional scoring systems for both VC and VF (one radiologist and one spine orthopaedics from IOR, one nephrologist from the National Research Council and one internist from University of Padua).

Each clinician will assess all radiographs to score VC and QVM, both via computer assisted procedures and via traditional visual inspection. To avoid bias, an interval of at least one week will be left between the computer assisted and visual scoring. To define intra-observer variability (i.e. repeatability), the whole dataset will be re-assessed three times.

02

Conditions studied

  • Vascular Calcification
  • Vertebral Fracture

Keywords

  • observer variability
  • kauppila score
  • quantitative vertebral morphometry
  • computer assisted procedure
  • abdominal aorta
  • lumbar spine
03

In context

Vascular Calcification

82 studies on the registry are indexed under Vascular Calcification; 17 are open to participants now.

This study's enrollment of 44 is below the median of 80 across 23 observational studies indexed under Vascular Calcification.

Browse Vascular Calcification studies →

Lead sponsor

Istituto Ortopedico Rizzoli is the lead sponsor of 304 studies on the registry; 103 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Sampling method
Non-probability sample

Study population

All patients that were included in a previous interventional trial of the sponsor institution aimed to compare the effectiveness of vertebroplastic and kyphoplastic augmentations of the throracolumbar spine. The choice of this population was driven by previous reports on similar populations stating a high prevalence of vascular calcifications.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients included in a previous interventional study (VTP vs KYPHO) of the sponsor.
  • Availability of diagnostic images (Dorso-lumbar radiographies taken in L-L projection).
  • Rx images will be screened for the presence of VC, retaining only those showing VC.
  • obtained prior to any study analysis-evaluation.

Exclusion criteria

Exclusion Criteria:

  • Images showing severe artefacts (usually due to presence of metallic devices) that alter the grayscale range and hinder correct identification of VC and vertebral fractures
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Case-only
Time perspective
Retrospective
Enrollment
44 participants (actual)
Patient registry
No

Groups and cohorts

  • Vascular Calcification Group

    Patients with prevalent vascular calcifications will be analysed to verify the intra- and inter-observer reliability of the score of abdominal aorta calcifications

    Diagnostic Test: Score of abdominal aorta calcifications

Interventions

  • Diagnostic testScore of abdominal aorta calcifications

    Radiographs showing VC will be used to assess whether the computer assisted VC scoring (primary objective) and Quantitative Vertebral Morphometry (QVM, limited to lumbar spine, secondary objective n.1) through the Calcify2D software are less variable with respect to the traditional visual scoring of VC and QVM.

    Also known as: Score of lumbar spine vertebral fractures

06

What researchers measure

Primary outcomes

  1. Observer variability in scoring Vascular Calcification at the abdominal aorta

    Observer variability (repeatability and reproducibility) in the assessment of vascular calcifications at the abdominal aorta according to a widely adopted scoring system (Kauppila et al., 1997): comparison between computer assisted and visual scoring.

    Time frame: through study completion, 1 year at maximum

Secondary outcomes

  1. Observer variability in scoring Vertebral Fractures at the lumbar spine

    Observer variability (repeatability and reproducibility) in the assessment of vertebral fractures in the lumbar spine according to Quantitative Vertebral Morphometry (Genant et al., 2000): comparison between computer assisted and visual scoring.

    Time frame: through study completion, 1 year at maximum

  2. Accuracy of computer assisted VC score

    Accuracy of VC score computed by Calcify2D software will be tested against a gold standard CT-based score

    Time frame: through study completion, 1 year at maximum

  3. Accuracy of computer assisted QVM

    Accuracy of QVM score computed by Calcify2D software will be tested for the detection of mild vertebral fractures against gold standard Magnetic Resonance imaging

    Time frame: through study completion, 1 year at maximum

07

Study locations

1 site
  • Istituto Ortopedico Rizzoli
    Bologna, BO 40136, Italy
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03839732
Collaborators
Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy, University of Padova
Responsible party
Sponsor
First posted
Feb 15, 2019
Start date
Nov 28, 2018
Primary completion
Oct 31, 2019
Completion
Apr 27, 2021
Last update
May 24, 2023

Study contacts

Enrico Schileo, Ph.D.
principal investigator · Istituto Ortopedico Rizzoli

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion